Stocksigma LogoStocksigma Logo

Gujarat Terce Corrects MD & CEO Re-appointment Tenure

Gujarat Terce Laboratories has corrected the tenure for the re-appointment of Mr. Aalap Prajapati as MD & CEO

Gujarat Terce Corrects MD & CEO Re-appointment Tenure

Gujarat Terce Laboratories Ltd 路 Change in Management 路 21 Aug 2026, 9:34 pm

Gujarat Terce Corrects MD & CEO Re-appointment Tenure Gujarat Terce Laboratories has corrected the tenure for the re-appointment of Mr. Aalap Prajapati as MD & CEO. An earlier intimation on 29 May'26 mistakenly stated a five-year term. The company now clarifies the correct tenure is three years, effective from 28 Oct'26 to 27 Oct'29. This revision was approved by shareholders at the 41st AGM on 21 Aug'26. Mr. Prajapati has over 15 years of pharmaceutical industry experience and is the son of Whole-Time Director, Mr. Natwarbhai Prajapati.

Original exchange filing (PDF)

More announcements from Gujarat Terce Laboratories Ltd

All Gujarat Terce Laboratories Ltd announcements